Loading...
Buy now for a momentum/swing attempt. PBFS is in a technically bullish trend (stacked moving averages, positive and expanding MACD) and hedge fund buying surged last quarter (+334.54%), which supports near-term upside even without a news catalyst. With pre-market at 13.99, price is pressing the first resistance area (~14.02); a clean push through that level favors a quick continuation move, while the main near-term risk is a pullback if it fails and slips back toward ~13.62 pivot / ~13.23 support.
Trend/Setup: Bullish. The moving averages are aligned positively (SMA_5 > SMA_20 > SMA_200), indicating an established uptrend. Momentum: MACD histogram is +0.0429 and expanding, confirming strengthening upside momentum. RSI: RSI_6 = 65.26 (neutral-to-firm). Not yet an extreme overbought reading, but it’s elevated enough that breakouts may be prone to brief pullbacks. Key levels: Pivot 13.623. Resistance: R1 14.018, R2 14.262. Support: S1 13.228, S2 12.983. Pre-market 13.99 is just below R1, so the stock is at a decision point. Pattern-based probabilistic trend: Similar-pattern analysis shows ~60% odds of gains of ~+1.48% next day, +2.85% next week, +9.73% next month, consistent with the bullish technical backdrop.
Intellectia Proprietary Trading Signals
Strong technical uptrend (bullish MA stack) with improving momentum (positive, expanding MACD).
Hedge funds are buying aggressively: buying amount increased 334.54% over the last quarter.
Revenue growth in the latest reported quarter (2025/Q
was +12.07% YoY, supporting top-line momentum.
Profitability weakened in the latest quarter (2025/Q3): net income -8.24% YoY and EPS -28.00% YoY, which can cap valuation expansion.
No recent news catalysts in the last week; upside is mostly technical/positioning-driven.
Price is sitting just under a key resistance (R1 ~14.02); rejection there could trigger a short-term pullback toward pivot/support.
Latest quarter: 2025/Q3. Revenue rose to 22.92M (+12.07% YoY), but earnings quality softened: net income fell to 4.33M (-8.24% YoY) and EPS declined to 0.18 (-28.00% YoY). Overall: top-line growth is solid, but margin/earnings pressure is a clear negative trend to monitor.
No analyst rating or price target change data was provided, so a Wall Street pros/cons consensus view cannot be confirmed from this dataset. From the available fundamentals, the key 'pro' would be revenue growth; the key 'con' is declining EPS/net income in the latest quarter. Politician/congress trading: no recent congress trading data available in the last 90 days.
